Oqory
Phase 1Oqory is a clinical-stage company developing advanced antibody-drug conjugates for the treatment of multiple oncology indications. We have a robust pipeline of clinical candidates and a complete platform for ADC discovery and development.
Founded
2021
Focus
AntibodiesBiologics
About
Oqory is a clinical-stage company developing advanced antibody-drug conjugates for the treatment of multiple oncology indications. We have a robust pipeline of clinical candidates and a complete platform for ADC discovery and development.
Company Info
TypePrivate
Founded2021
LocationBoston, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile